INHIBACE Tablet Ref.[27888] Active ingredients: Cilazapril

Source: Health Products and Food Branch (CA)  Revision Year: 2020 

Product name

INHIBACE – Cilazapril tablets 2.5 mg and 5.0 mg.

Summary product information

Route of AdministrationDosage Form/StrengthNon-medicinal Ingredients
OralTablet 2.5 mg, 5 mgLactose monohydrate, cornstarch, hydroxypropyl methylcellulose, talc, sodium stearyl fumarate and titanium dioxide. Iron oxide is present as the colouring agent in the tablet.

Dosage forms, composition and packaging

INHIBACE (cilazapril) is available in film-coated tablets containing:

  • 2.5 mg cilazapril – pinkish-brown, oval shaped, single scored biconvex tablets, imprinted CIL 2,5. Available in bottles of 100 tablets and blister packs of 28 tablets.1
  • 5 mg cilazapril – reddish-brown, oval shaped, single scored biconvex tablets, imprinted CIL 5. Available in bottles of 100 tablets and blister packs of 28 tablets.1

INHIBACE 2.5 mg and 5 mg film-coated tablets contain 2.5 mg and 5 mg anhydrous cilazapril, as cilazapril monohydrate, respectively. Non-medicinal ingredients: the tablets also contain lactose monohydrate, cornstarch, hydroxypropyl methylcellulose, talc, sodium stearyl fumarate and titanium dioxide. Iron oxide is present as the colouring agent in the 2.5 mg and 5 mg tablets.

1 Blister packs are not marketed in Canada.

Marketing Informations Authorization Dates
Authorization holder:

CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Germany, www.cheplapharm.com

Imported By: MSD Inc., 8449 Lawson Road, Unit 102, Milton ON, L9T 9L1

 Submission control number:

235666

 		Date of approval:

March 22, 1993

Date of revision:

June 2, 2020

Drugs

Drug Countries
INHIBACE Austria, Canada, Poland, Turkey, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈